Skip to main content

What the FDA labels say about taking them together

Benazepril and triamterene

Benazepril's FDA label of September 30, 2025 names triamterene in its drug interactions section; triamterene's label does not name benazepril itself but warns about its class (ACE inhibitors). The benazepril label: “Hyperkalemia Potassium-sparing diuretics can increase the risk of hyperkalemia.”

Check it at the source: the benazepril FDA label on DailyMed (effective September 30, 2025, Validus Pharmaceuticals LLC); the triamterene FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the benazepril label say about triamterene?

Benazepril label, drug interactions

Hyperkalemia Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia.

Source: FDA drug label (Lotensin), Validus Pharmaceuticals LLC, effective September 30, 2025 (SPL set 2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e), via openFDA; the full label on DailyMed

What does the triamterene label say about benazepril?

Triamterene's label does not name benazepril itself; it warns about its class (ACE inhibitors):

Triamterene label, drug interactions

Potassium-sparing agents should be used with caution in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to an increased risk of hyperkalemia.

Source: FDA drug label (Dyrenium), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set ebb177c0-d45d-4443-a85a-e76bd9931a42), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

21Benazepril generic labelers
3Triamterene generic labelers
BenazeprilTriamterene
Labeled forHigh blood pressureHeart failure, Edema (fluid retention)
Boxed warningYesYes
Pharmacy cost (NADAC)$0.0789 per tablet 20 mg tablet$5.98 per capsule 50 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?